SPDWvsXBI
SPDR Portfolio Developed World ex-US ETF against SPDR S&P Biotech ETF — the fee, the flows, the book, and a year head-to-head.
Head to head
| SPDW | XBI | |
|---|---|---|
| Expense ratio | 0.030% | 0.35% |
| Assets | $41.6B | $10.3B |
| Net flow, 1 month | +$917M | −$8M |
| Net flow, 1 year | +$5.3B | +$675M |
| Return, YTD | +9.2% | +19.6% |
| Return, 1 year | — | — |
| Avg daily volume | 3.8M | 9.2M |
| Holdings | 2437 | 165 |
| Listed | Apr 20, 2007 | Jan 31, 2006 |
| Options market | Yes | Yes |
MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS